PATENT CLAIM ANALYSIS

Application Number: 15915842
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "455000"]

Abstract:
The invention provides a compound of formula (I) wherein: A, B, C, D, W, X, Y and Z are each independently selected from H and OH; or a salt thereof; for use in the treatment and/or prophylaxis of a condition, disease or disorder in a subject, wherein the compound or salt is orally administered to a subject in a daily amount of from 2.8 to 6.6 mmol per day, over a period of at least 21 days. Also are provided are the compound of formula (I) for use in increasing mitophagy and/or autophagy, maintaining and/or improving muscle function and administration as a dietary, nutritional and/or health supplement.

Claim (Index 41):
The method of  claim 37 , wherein urolithin A is administered in an amount from 9 mg/kg/day to 18 mg/kg/day.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.64935
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15218790', '15757293', '13336841', '15532280', '11908952']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7960831193094622
- 35 USC 102 Novelty (BERT): 0.5064871896490022
- Combined Prediction Score: 0.7671235263434162
- Mean Citation Score: 265.293968
- Max Citation Score: 272.13947
- Similarity Product: 209.33165038271667

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test